首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.
【2h】

Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development.

机译:小鼠慢性移植物抗宿主病作为系统性红斑狼疮的模型:免疫抑制剂对疾病发展的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The effect of a number of drugs commonly used to treat the more severe exacerbations of the autoimmune disease systemic lupus erythematosus (SLE) in humans has been investigated in the murine chronic graft-versus-host (GVH) induced model of lupus. This was undertaken in order to determine the value of this model for the investigation of immunomodulant drugs, with particular regard to the reproducibility of disease induction and methods of monitoring disease progression. The drugs were azathioprine, cyclophosphamide, cyclosporin A and dexamethasone. All of these, except for azathioprine, reduced disease severity, assessed as the development of lupus nephritis. Anti-ssDNA autoantibodies were also reduced in titre in the dexamethasone-treated group. Overall, these findings, combined with the reproducible induction of disease seen in this model, support the use of chronic GVH disease as a model for SLE and show that the induced disease can be ameliorated by drugs effective in the treatment of SLE in humans.
机译:已经在鼠类慢性移植物抗宿主(GVH)诱导的鼠模型中研究了许多通常用于治疗人类自身免疫性疾病系统性红斑狼疮(SLE)病情加重的药物的作用。进行此操作是为了确定该模型在研究免疫调节药物方面的价值,尤其是在疾病诱导的可重复性和监测疾病进展的方法方面。这些药物是硫唑嘌呤,环磷酰胺,环孢菌素A和地塞米松。除硫唑嘌呤外,所有这些均降低了疾病的严重程度,并被评估为狼疮性肾炎的发展。在地塞米松治疗组中,抗-ssDNA自身抗体的滴度也降低了。总体而言,这些发现与该模型中疾病的可再现性诱导相结合,支持将慢性GVH疾病用作SLE模型,并表明可以通过有效治疗人类SLE的药物来缓解诱导的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号